Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Off-label use of oncology drugs: too much, too little, or just right?

Off-label use of oncology drugs: too much, too little, or just right? J Natl Compr Canc Netw. 2013 May 01; 11(5):505-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.